James B. Hall

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies.

H. Burris, U. Matulonis, F. Muggia, 2007, Gynecologic oncology.